APA (7th ed.) Citation

OY, R., AM, C., O, S., B, P., S, A., J, P., . . . RW, J. (2024). Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy. BioRxiv : the preprint server for biology. https://doi.org/10.1101/2024.02.12.579184

Chicago Style (17th ed.) Citation

OY, Revach, et al. "Disrupting CD38-driven T Cell Dysfunction Restores Sensitivity to Cancer Immunotherapy." BioRxiv : The Preprint Server for Biology 2024. https://doi.org/10.1101/2024.02.12.579184.

MLA (9th ed.) Citation

OY, Revach, et al. "Disrupting CD38-driven T Cell Dysfunction Restores Sensitivity to Cancer Immunotherapy." BioRxiv : The Preprint Server for Biology, 2024, https://doi.org/10.1101/2024.02.12.579184.